112 related articles for article (PubMed ID: 23640237)
21. Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET.
Binderup T; Knigge U; Loft A; Mortensen J; Pfeifer A; Federspiel B; Hansen CP; Højgaard L; Kjaer A
J Nucl Med; 2010 May; 51(5):704-12. PubMed ID: 20395333
[TBL] [Abstract][Full Text] [Related]
22. Bilateral ovarian metastases from gastric carcinoma on FDG PET/CT.
Ho L; Wassef H; Nakla A; Henderson R
Clin Nucl Med; 2012 May; 37(5):524-7. PubMed ID: 22475913
[TBL] [Abstract][Full Text] [Related]
23. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Han A; Xue J; Hu M; Zheng J; Wang X
Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
[TBL] [Abstract][Full Text] [Related]
24. The impact of (18)F-FDG-PET/CT on Merkel cell carcinoma management: a retrospective study of 66 scans from a single institution.
George A; Girault S; Testard A; Delva R; Soulié P; Couturier OF; Morel O
Nucl Med Commun; 2014 Mar; 35(3):282-90. PubMed ID: 24240193
[TBL] [Abstract][Full Text] [Related]
25. [Radiological study on early gastric cancer in the cardia].
Higo K
Igaku Kenkyu; 1988 Oct; 58(5):250-66. PubMed ID: 3252672
[No Abstract] [Full Text] [Related]
26. Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors.
Scanga DR; Martin WH; Delbeke D
Clin Nucl Med; 2004 Feb; 29(2):86-90. PubMed ID: 14734903
[TBL] [Abstract][Full Text] [Related]
27. Extramedullary gastric relapse of acute lymphoblastic leukemia following allogeneic stem cell transplant: staging with F-18 FDG PET/CT.
Ciarallo A; Makis W; Novales-Diaz JA; Michel RP
Clin Nucl Med; 2011 Aug; 36(8):e90-2. PubMed ID: 21716008
[TBL] [Abstract][Full Text] [Related]
28. Value of ¹⁸F-FDG PET/CT in the diagnosis of primary gastric cancer via stomach distension.
Ma Q; Xin J; Zhao Z; Guo Q; Yu S; Xu W; Liu C; Zhai W
Eur J Radiol; 2013 Jun; 82(6):e302-6. PubMed ID: 23434453
[TBL] [Abstract][Full Text] [Related]
29. Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Santhanam P; Taïeb D
Clin Endocrinol (Oxf); 2014 Dec; 81(6):789-98. PubMed ID: 25056984
[TBL] [Abstract][Full Text] [Related]
30. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y
Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223
[TBL] [Abstract][Full Text] [Related]
31. Significance of (18)F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography.
Takahashi H; Ukawa K; Ohkawa N; Kato K; Hayashi Y; Yoshimoto K; Ishiyama A; Ueki N; Kuraoka K; Tsuchida T; Yamamoto Y; Chino A; Uragami N; Fujisaki J; Igarashi M; Fujita R; Koyama M; Yamashita T
Ann Nucl Med; 2009 Jun; 23(4):391-7. PubMed ID: 19399579
[TBL] [Abstract][Full Text] [Related]
32. Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis.
Herrmann K; Ott K; Buck AK; Lordick F; Wilhelm D; Souvatzoglou M; Becker K; Schuster T; Wester HJ; Siewert JR; Schwaiger M; Krause BJ
J Nucl Med; 2007 Dec; 48(12):1945-50. PubMed ID: 18006614
[TBL] [Abstract][Full Text] [Related]
33. Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.
Kayani I; Bomanji JB; Groves A; Conway G; Gacinovic S; Win T; Dickson J; Caplin M; Ell PJ
Cancer; 2008 Jun; 112(11):2447-55. PubMed ID: 18383518
[TBL] [Abstract][Full Text] [Related]
34. The utility of FDG-PET in the preoperative staging of esophageal cancer.
Gananadha S; Hazebroek EJ; Leibman S; Berry H; Osgood L; Shon IH; Pavlakis N; Marx G; Smith GS
Dis Esophagus; 2008; 21(5):389-94. PubMed ID: 19125791
[TBL] [Abstract][Full Text] [Related]
35. A hepatoid adenocarcinoma of the stomach evaluated with (18)F-FDG PET/CT: intense (18)F-FDG uptake contrary to the previous report.
Seo HJ; Chung JK; Go H; Cheon GJ; Lee DS
Clin Nucl Med; 2014 May; 39(5):442-5. PubMed ID: 24152637
[TBL] [Abstract][Full Text] [Related]
36. Hepatocellular carcinoma and gastroenteropancreatic neuroendocrine tumors: potential role of other positron emission tomography radiotracers.
Jadvar H
Semin Nucl Med; 2012 Jul; 42(4):247-54. PubMed ID: 22681673
[TBL] [Abstract][Full Text] [Related]
37. ¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.
Groheux D; Hindié E; Marty M; Espié M; Rubello D; Vercellino L; Bousquet G; Ohnona J; Toubert ME; Merlet P; Misset JL
Eur J Radiol; 2014 Oct; 83(10):1925-33. PubMed ID: 24985086
[TBL] [Abstract][Full Text] [Related]
38. Staging and treatment response evaluation in a metastatic neuroendocrine tumor of the pancreas with G2 grading: insights from multimodality diagnostic approach by F-18-FDG and Ga-68-DOTANOC PET/CT.
Treglia G; Plastino F; Campitiello M
Endocrine; 2013 Jun; 43(3):729-31. PubMed ID: 23247870
[No Abstract] [Full Text] [Related]
39. The role of combined Ga-DOTANOC and (18)FDG PET/CT in the management of patients with pancreatic neuroendocrine tumors.
Partelli S; Rinzivillo M; Maurizi A; Panzuto F; Salgarello M; Polenta V; Delle Fave G; Falconi M
Neuroendocrinology; 2014; 100(4):293-9. PubMed ID: 25301162
[TBL] [Abstract][Full Text] [Related]
40. Individualized surgical strategies for cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
